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Objective: To evaluate the effect of time between the movements/steps, angle of body 
movements as well as the angular velocity of the maneuvers in an in vitro model of a 
semicircular canal (SCC) to improve the efficacy of the Sémont maneuver (SM) in benign 
paroxysmal positional vertigo.
Materials and Methods: Sémont maneuvers were performed on an in  vitro SCC 
model. Otoconia trajectories were captured by a video camera. The effects of time 
between the movements, angles of motion (0°, 10°, 20°, and 30° below the horizontal 
line), different angular velocities (90, 135, 180°/s), and otoconia size (36 and 50 μm) on 
the final position of the otoconia in the SCC were tested.
results: Without extension of the movements beyond the horizontal, the in vitro experi-
ments (with particles corresponding to 50 μm diameter) did not yield successful canalith 
repositioning. If the movements were extended by 20° beyond the horizontal position, 
SM were successful with resting times of at least 16  s. For larger extension angles, 
the required time decreased. However, for smaller particles (36 μm), the required time 
doubled. The angular maneuver velocity (tested between 90 and 180°/s) did not have a 
major impact on the final position of the otoconia.
interpretation: The two primary determinants for success of the SM are the time 
between the movements and the extension of the movements beyond the horizontal. 
The time between the movements should be at least 45 s. Angles of 20° or more below 
horizontal line (so-called Sémont+) should increase the success rate of SM.
Keywords: vertigo, BPPV, sémont liberatory maneuver, canalolithiasis, semicircular canal
inTrODUcTiOn
Vertigo and dizziness are two of the most frequent symptoms occurring in neurology departments, 
with a lifetime prevalence of about 30% (1, 2). Their most common cause is benign paroxysmal 
positional vertigo (BPPV). BPPV is reported to have a prevalence between 10.7 and 64.0 cases per 
100,000 population and a lifetime prevalence of 2.4% (3–5). Sémont’s liberatory maneuver (SM) (6) 
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FigUre 1 | Unsuccessful sémont maneuver. Schematic drawing of an unsuccessful Sémont maneuver. After the patient with right-sided BPPV is moved by 
180° from right to the left, the particles do not move ampullofugally but ampullopetally into the direction of the cupula. This causes an ampullopetal cupula deflection 
with a reversed positional nystagmus with the quick phase beating to the left and downward. It indicates that the liberatory maneuver failed and must be repeated 
[adapted from Brandt et al. (8)].
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is an established method for treating BPPV due to canalolithiasis 
of a posterior semicircular canal (SCC) (7, 8). The original ver-
sion was simplified and now consists of a two-step change in body 
position to flush otolithic debris out of the SCCs and back into 
the utricle (6, 9). The patient is seated sideways on an examination 
couch and is moved rapidly from the sitting position to the lying 
position with the head turned 45° opposite to the direction of 
movement. Sémont et al. (6) suggested that the patient remains 
for 2–3 min in this position. Then, the patient is rapidly moved 
in a 180° cartwheel motion to the opposite side without pause, 
while the head remains turned by 45°. The patient is brought into 
a seated position after resting for 5 min (6). Such a long time, 
however, is not generally recommended anymore (2, 10).
Although some studies indicate an effectiveness of SM of over 
70% (11) and of 80–90% (12), clinical experience shows that the 
SM has to be repeated several times, BPPV remains unresolved in 
some cases, or it is subject to recurrences within a short time. Lee 
et al. (13) report an effectiveness of SM of less than 40% after the 
first maneuver. Moreover, it is “unclear what strategy should be 
pursued if the initial maneuver is not effective” (14), and a success 
rate of only 58% is reported for self-administered SM (4), which 
underlines the importance of effective teaching of repositioning 
maneuvers (15). Different recommendations have been made in 
clinical practice as to how to perform the SM with regards to the 
time between the different steps and the angular velocity of the 
body movements: recommended times between the two move-
ments range from 30 s to 5 min (6, 16, 17); according to Sémont 
et al. (6), the movements should be performed quickly (without 
quantitative specification of velocity), while others suggested 
high acceleration with a maximal time duration of 1.5 s for the 
second movement by 180° (18). None of these recommendations 
were tested.
For the present study, we take the position that BPPV is due to 
canalolithiasis, i.e., due to free-floating particles in the SCC (19). 
An intraoperative study with patients undergoing labyrinthine 
surgery related these particles to degenerated otoconia and showed 
a significant association between such particles and BPPV (20). 
Here, we are excluding the case of cupulolithiasis, which is caused 
by cupular deposits (21) that alter the biomechanics of the cupula 
leading to positional nystagmus (22). Experiments with bullfrog 
labyrinths also indicated that canalolithiasis is more likely the 
cause for BPPV than cupulolithiasis (23). This was confirmed by 
theoretical work indicating that the nystagmus expected due to 
canalolithiasis is more consistent with clinical observations than 
a nystagmus due to cupulolithiasis (22).
Theoretically, it is ideal if the otoconia reach the lowest point 
relative to gravity in the SCC after each step of the SM to reduce 
the risk that they move toward the cupula, which would result in 
a failure of the maneuver (8) (Figure 1).
Therefore, we evaluated the different parameters that could 
have an effect on the movement of the otoconia and on their final 
position during the SM and thereby on the efficacy of the SM: first, 
the angular velocity during the maneuver; second, the resting 
time after the first movement of the patient; and third, the range 
of movement. We performed experiments with an in vitro model 
of an SCC (SCC model) with canaliths (24) to obtain quantita-
tive evidence, relating the success of the SM to these therapeutic 
parameters. On the basis of these findings, we formulate clinical 
recommendations to increase the success rate of the SM.
MaTerials anD MeThODs
Two sets of in vitro experiments were conducted in this study. 
In the first set, the SCC model was mounted on a computer-
controlled stepper motor, which performed parametrized SMs 
in a repeatable fashion. The center of rotation was at the center 
of the SCC model. In the second set of experiments, the center 
of rotation differed from that of the SCC model, mimicking a 
patient pivoting about the pelvis. To this end, the SCC model 
was mounted on a lever-arm device operated by an experienced 
neuro-otologist.
Parametrized sémont Maneuver
The parametrized SM (Figure 2) used in the present study con-
sisted of four phases: (1) first movement of the patient to the right 
by an angle of 90° + α+; (2) resting period of Tp seconds while the 
patient lies on the right side; (3) second movement of the patient 
to the left by 180° + 2α+ so that the SCC comes to rest on the 
left side at an angle of 90° + α+; and (4) final waiting period and 
assessment of the success of the maneuver.
This maneuver is defined by three parameters: the angular 
maneuver velocity α ° / s , which defines the speed for the two 
FigUre 2 | schematic drawing of parametrized sémont maneuver. 
Parametrized SM with first movement to the right (1), resting time TP, second 
movement to the left (2), and a final resting period on the left side.
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movements; the resting time Tp [s] between the first and second 
step; and the extension angle α+ [°], which defines how much the 
SCC is rotated beyond the horizontal position. This extended 
movement range between the different body positions can be 
attained by an additional tilting of the head beyond the horizontal 
as confirmed by SMs performed on test persons.
In Vitro Model for scc with canalolithiasis
A scaled SCC model (24) was used to analyze the behavior of 
otoconia. For simplicity, the SCC model was limited to the mem-
branous duct of a single SCC; the ampulla and the utricle were 
filled with a viscous fluid modeling the endolymph (Figure 3A). 
The two other SCCs, the saccule and the bony labyrinth were 
omitted. Small particles were added to model otoconia. For better 
handling and accessibility, the SCC model and the particles were 
five times larger than in a human inner ear. The slender membra-
nous duct of the SCC was modeled by a PVC tube (LabMarket, 
Ludwigshafen, Germany) with an inner diameter of 1.5 mm. This 
tube opened at one end to the utricle. The other end connected 
to the ampulla, which was closed by a 50-μm elastic membrane 
(Goodfellow Cambridge, Huntingdon, UK) modeling the cupula. 
We used Glycerintricapprylat (Blaser Swisslube, Hasle-Rüegsau, 
Switzerland) as a model for the endolymph. The otoconia were 
modeled by steel microspheres (MPS Micro Precision Systems, 
Biel, Switzerland) made of E52100 steel with diameters D of 
180 and 250 μm. The material parameters (e.g., fluid viscosity, 
fluid density, particle density) were chosen so that the dynamic 
behavior of the SCC model was comparable to a human SCC with 
otoconia. For the geometrical scaling factor f =  5, the correct 
physical scaling (24) required, for example, that the fluid viscosity 
was f2 =  25 times larger than the viscosity of endolymph. For 
the particle density, the physical scaling requires that the ratio 
between particle and fluid density is 1 + f ⋅ (ρp/ρ − 1) = 9.5 (where 
ρp/ρ = 2.7 is the ratio of otoconia and endolymph density).
Table 1 summarizes the geometrical and physical properties 
of the scaled SCC model. The last column of Table 1 shows the 
values for a corresponding unscaled SCC with a major radius of 
3.2 mm and a slender duct radius of 0.15 mm, which compares 
well to measurements of human SCC (25). The unscaled fluid 
density was 8% higher than the endolymph viscosity of 10−6 m2/s 
(26), and the unscaled particle density was about 9% lower than 
the density of otoconia (2700 kg/m3) (26). We can further quan-
tify this difference by computing the particle settling time scale 
(24), which describes a characteristic time required by a canalith 
to fall through a short section of the SCC. It amounted to 1.17 s 
in the SCC model and to 0.92 s in a corresponding human SCC. 
Therefore, the particles in the SCC model settled about 20% more 
slowly than in a corresponding human SCC.
For the validation of this model, a 120° maneuver of the SCC 
model with particles has been studied (24). Particle motion (set-
tling time and velocity) as well as cupula displacements in the 
in  vitro model were shown to be comparable to the positional 
nystagmus in BPPV patients.
experimental setup with stepper Motor
For the first experimental setup, the SCC model was mounted 
on a stepper motor, which rotates the model (Figure  3B). The 
SCC model was aligned with the plane of rotation to mimic the 
turning of the head by 45°. The stepper motor was controlled by a 
personal computer to perform parametrized SMs. The movement 
of the particles was recorded with a video camera (JAI RM-6740 
GE, Stemmer Imaging, Pfäffikon, Switzerland) and a 16-mm 
MegaPixel fixed FL lens (Edmund Optics, Karlsruhe, Germany). 
The recorded videos were analyzed with MATLAB (MathWorks, 
Natick, MA, USA).
lever-arm setup for Manual Maneuver
For the second experimental setup, the SCC model was mounted 
on a lever-arm device (Figure 3C) that could be freely rotated 
to the left and right. Adjustable mechanical stops on the left 
and right sides limited the range of motion of the lever arm to 
±(90° + α+). The camera was fixed on the lever arm so that it 
moved with the SCC model. The length of the lever arm was 
72 cm, thus corresponding to a typical distance from the pelvis 
to the SCC in average European men (DIN 33 402-2:2007). Two 
handles attached to the lever arm allowed an experienced neuro-
otologist to perform the parametrized SM. A stopwatch was used 
to perform the SM with the given velocity and resting times. 
In addition, the SM was monitored electronically by attaching 
accelerometers (EyeSeeCam, Fürstenfeldbruck, Germany) to the 
SCC model.
experimental Protocol
Experiments with the stepper-motor setup and with the lever-
arm setup were performed for a range of different parameters for 
the SM and for different particle sizes (Table 2). For simplicity, 
TaBle 1 | geometrical and physical properties of the scc model 
together with the corresponding unscaled parameters assuming a 
geometrical scaling factor of 5.
scc model Unscaled scc
SCC radius (mm) R 16 3.2
Radius of slender duct (mm) a 0.75 0.15
Fluid viscosity (m2/s) ν 27 × 10−6 1.08 × 10−6
Fluid density (kg/m3) ρe 945 1000
Particle diameter (μm) D 180, 250 36, 50
Particle density (kg/m3) ρp 7800 2450
FigUre 3 | experimental setup. (a) Scaled SCC model; (B) experimental setup with stepper motor; (c) setup for the lever-arm experiments.
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only one particle was used. We varied the extension angle α+ 
between 0° and 30° in steps of 10°, and the tested maneuver 
velocities α+ were 90, 135, and 180°/s. These parameter ranges 
were determined to be relevant for clinical maneuvers based on 
ad  hoc measurements of several SMs using video-oculography 
goggles with accelerometers (EyeSeeCam, Fürstenfeldbruck, 
Germany).
At the beginning of each experiment, the SCC model was 
positioned such that the angle between the horizontal and the 
ampulla amounted to 32° (Figure 3A). This corresponds to the 
SCC orientation in upright position (27, 28). Before starting the 
experiment, it was ensured that the PVC tube was free of air bub-
bles and that the particle had settled at the lowest position in the 
SCC, i.e., 58° away from the ampulla.
After the second movement of the SCC model, the SM was 
considered successful if the particle settled in the utricle or unsuc-
cessful if it settled in the ampulla (cf. Figure 3A).
TaBle 2 | experimental configurations (particle diameter D, extension 
angle α+, maneuver velocity v) and the corresponding critical resting 
times (printed in bold) determined by stepper-motor and by lever-arm 
experiments (“X” indicates that a successful sM could not be performed 
for the tested range of resting times).
Particle diameter D extension  
angle α+
Maneuver velocity v
90°/s 135°/s 180°/s
stepper-motor experiments
180 μm 20° 29 s 26 s 24 s
250 μm 0° X X X
250 μm 10° X 33 s 26 s
250 μm 20° 16 s 13 s 12 s
250 μm 30° 9 s 8 s 8 s
lever-arm experiments
250 μm 20° 16 s (12 s) 11 s (8 s) 10 s (8 s)
For the lever-arm experiments, the lower values in parentheses indicate the critical 
resting times for which SMs were only intermittently successful.
FigUre 4 | Particle trajectories during sémont maneuver. Particle positions at different points in time during the SM (D = 250 μm, α+ = 20°). (a) Unsuccessful 
maneuver (Tp = 5 s, v = 135°/s); (B) successful maneuver (Tp = 45 s, v = 135°/s). From left to right: particle position (red circle) at the end of the first movement, 
after the resting time, after the second movement, and after the final resting time when the particle has settled (a) in the ampulla or (B) in the utricle of the SCC 
model.
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For a given maneuver velocity, extension angle, and particle 
diameter, the resting time Tp was slowly increased from experi-
ment to experiment in increments of 1 s or more (starting with a 
resting time of 5 s). This procedure was continued until a critical 
time could be identified, which marked the border between 
unsuccessful and successful repositioning, i.e., the critical time 
indicates the shortest possible resting time after which particles 
can be successfully repositioned.
For configurations close to the critical time, the results from 
the lever-arm experiments showed some variability, i.e., subse-
quent instances of the same experiment did not always yield the 
same results. Therefore, each experiment was repeated several 
times, and a maneuver was considered successful or unsuccessful 
only if at least three consecutive repetitions of that maneuver 
yielded successful (or unsuccessful, respectively) reposition-
ing of the canalith. The stepper-motor experiments exhibited 
a high repeatability due to the computer-controlled maneuver. 
Nevertheless, the stepper-motor experiments were also repeated 
close to the critical time to ensure that external factors (e.g., room 
temperature, vibrations) did not affect the results.
resUlTs
canalith Trajectories
Figure 4 illustrates the trajectory of a canalith in the SCC model, 
showing the position (and direction of motion) of the particle 
in stepper-motor experiments at different points in time for 
two exemplary SMs (also see the Video S1 in Supplementary 
Material). Figure  4A shows an unsuccessful repositioning 
(Tp = 5 s, v = 135°/s). The resting time Tp after the first movement 
is too short; the particle does not have enough time to settle at 
the lowest point of the SCC before the second movement begins. 
Consequently, the particle is not moved beyond the apex by the 
second movement, and it falls into the ampulla (unsuccessful SM). 
FigUre 5 | experimental results – critical resting times. Critical resting times as function of the maneuver velocity for various experimental configurations.  
(a) Stepper-motor experiments with D = 250 μm (•) and α+ = 10°, 20°, 30° and with D = 180 μm (▴) and α+ = 20°; (B) lever-arm experiments (◾) with D = 250 μm 
and α+ = 20°. The shaded area indicates the range of resting times for which the lever-arm experiments did not yield conclusive results. For comparison, the critical 
resting times from the stepper-motor experiments for D = 250 μm (•) and α+ = 20°are shown as well [identical to data shown in (a)].
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In the SM in Figure 4B (Tp = 45 s, v = 135°/s), the resting time 
is longer; the particle has time to settle at the lowest point of the 
SCC after the first movement. Therefore, the particle in Figure 4B 
is moved beyond the apex by the second movement, and it falls 
into the utricle of the SCC model (successful SM).
Variation of extension angle
A set of experiments was performed with the stepper-motor setup 
using a particle with a diameter of 250 μm, different extension 
angles α+, and different maneuver velocities. For α+ =  0°, all 
attempts to successfully reposition the canaliths failed. Even in 
experiments with non-physiologically high velocities and/or 
extensively long resting times, it was not possible to reposition 
the particle into the utricle.
For α+ = 10° and v = 90°/s, a successful canalith reposition-
ing was also not possible. The maneuver was successful only for 
maneuver velocities of 135 and 180°/s, if the resting time was at 
least 33 and 26 s, respectively. For an extension angle of 20°, resting 
times of at least 16 s were required for a successful repositioning 
of the particle. Higher maneuver velocities required somewhat 
shorter resting times. For α+ =  30°, the SM was successful for 
Tp even below 10 s, and the maneuver velocity had only a minor 
effect on the critical time. The resulting critical resting times are 
summarized in Table 2 and in Figure 5A.
Variation of Particle size
To assess the effect of the particle size on the outcome of the SM, 
the stepper-motor experiments were repeated for α+ = 20° with 
a smaller particle size D = 180 μm (Figure 5A and Table 2). The 
critical times Tp (29 s for 90°/s, 26 s for 135°/s, 24 s for 180°/s) 
were approximately twice as high as the critical times for the large 
particle.
lever-arm experiments
Experiments with the lever-arm setup were carried out to assess 
the effect of the shifted pivot on the canalith repositioning. 
Figure 5B and Table 2 present the results for a particle of 250 μm 
diameter and an extension angle of α+ = 20°. For a certain range of 
resting times, the results were inconclusive, i.e., in some instances 
the maneuver was successful, but in other instances it failed. This 
can be attributed to small variations in the manually performed 
maneuvers.
DiscUssiOn
The major findings of this in  vitro study on the theoretically 
relevant parameters for SM are the following. First, a sufficiently 
long resting time between the two movements is a primary deter-
minant for successful SMs. Second, it is advantageous to extend 
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the movement of the head beyond the earth horizontal by 20° 
(so-called Sémont+); if the SM is only performed to the earth 
horizontal, the otoconia are unlikely to be repositioned success-
fully. Third, the angular velocity has only a minor effect on the 
success of the SM in the tested range (90, 135, 180°/s).
Basing clinical recommendations on the experimental results 
would seem likely to improve the effectiveness of the SM. However, 
it is necessary to consider the limitations of the present experi-
ments. First, we have to assess the differences between the SM 
performed in the stepper-motor experiments and an actual SM 
performed on a patient. To this end, we compared stepper-motor 
results with results from the lever-arm experiments, which closely 
modeled the actual clinical situation. Second, the particle size has 
an effect on the success of the maneuver. This is a critical point 
because the canalith size is not known for individual patients. In 
the following paragraphs, we discuss both points in detail before 
formulating clinical recommendations.
The experiments with the lever-arm setup showed that the 
critical times between the steps are slightly less than for cor-
responding configurations with the stepper-motor experiment. 
This indicates that centripetal accelerations that are only present 
in the lever-arm setup are beneficial for canalith repositioning. 
Therefore, the critical resting times in clinical practice are prob-
ably less than in the stepper-motor experiments. However, the 
difference in the critical times between lever-arm and stepper-
motor setup is 2 s or less, which is quite small given that other 
uncertainties (e.g., unknown particle size) can lead to greater 
differences.
After the first movement by 90° +  α+, the particles in our 
experiment settled at the lowest point of the SCC after approxi-
mately 10–30 s depending on maneuver velocity, extension angle, 
and particle size. For comparison, experiments (29) with glass 
beads (15–25 μm diameter) in SCC of Opsanus Tau (inclined by 
21°) indicated that the beads were moving at velocities of up to 
80 μm/s and that they settled after 62–65 s. Furthermore, theo-
retical and computational studies indicate that the settling speed 
scales with the inverse of the particle cross-section (22, 24, 30). 
According to this theory, small particles (180 μm) require nearly 
twice as long to settle as large particles (250 μm) because the ratio 
of their respective cross-sections is nearly two: π ⋅ (250 μm)2/π ⋅ 
(180 μm)2 ≈ 1.9. This agrees quite well with the doubling of criti-
cal times illustrated in Figure 5A.
Human utricular otoconia are reported to have diameters 
ranging from 1 to 30 μm (31, 32). Canaliths are thought to con-
sist of larger lumps of multiple otoconia (19) as well as of single 
otoconia, which may detach from the otolith macula due to struc-
tural degeneration (33), drugs (34), and mechanical insult (23). 
Experiments in animal models (35) suggested that debris moving 
inside an SCC stimulates ampulla receptors only if the particles are 
of a suitable size (microsphere diameter exceeded about 50 μm). 
Theoretical and numerical studies predict a positional nystagmus 
of only 2°/s for a canalith with a diameter of 15 μm, 5°/s for a 
30-μm canalith (22), and a nystagmus of approximately 20°/s for a 
canalith with a diameter of 57 μm (36). These results suggest that 
single otoconia of 15 μm or less are clinically not very relevant 
targets for canalith repositioning with the SM. For our further 
discussion, we postulate that the SM should target otoconia with 
a diameter of at least 25 μm. Such otoconia would correspond to 
125 μm-particles in our experiment. Their cross-section is 4 times 
smaller than for 250 μm-particles, with the result that the critical 
times are expected to be 4 times larger than the critical times for 
the 250 μm-particles reported in Table 2.
Finally, it should be kept in mind that particles in the SCC 
model settle approximately 20% more slowly than in a human 
SCC. Therefore, the predicted critical times can be considered 
conservative estimates.
On the basis of the present results and discussion, we propose 
the following clinical recommendations to improve the success 
rate of the SM.
First, the time between the two movements should be at least 
45 s; second, the measured angle for the first step of the SM should 
ideally be 110° (not only 90° as had been recommended) and for 
the second step 220° (not only 180°). If a patient tolerates an 
extension angle of 30° beyond the horizontal, the time between 
the steps can be reduced. Third, the SM should be performed with 
an angular velocity of around 135°/s (i.e., about 0.66 s for the 90° 
movement and about 1.33 s for the 180° movement). Successful 
SMs can also be performed at lower velocities (90°/s), which is of 
particular interest in immobile or obese patients, provided that 
the resting time is increased to at least 60 s.
These recommendations are based on the in vitro model with 
single spherical particles. The effect of multiple, non-spherical 
particles and of possible lumps of particles has not yet been con-
sidered. Nevertheless, the present results could have a consider-
able impact on daily clinical practice. Since the time between the 
movement and the body position are easy to measure, this could 
be the theoretical basis of controlled clinical trials to increase the 
efficacy of the treatment of the most frequent cause of vertigo. 
Further, these findings could provide the basis for a clinical 
trial comparing Sémont+ with the regular SM in terms of their 
efficacy.
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